Back to search
Major Adverse Cardiac Events
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Major Adverse Cardiac Events trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Major Adverse Cardiac Events trials you may qualify forDAN-ZOSTER is a nationwide randomized study investigating whether vaccination against herpes zoster (shingles) can reduce the risk of cardiovascular disease and…
The rationale of our study is to observe the incidence of MACE in RA patients treated with tofacitinib along with statins with one or more cardiovascular diseas…
The main purpose of the study is to evaluate the efficacy of selnoflast compared with placebo in participants with atherosclerosis, at high-risk for major adver…
Heart disease remains the leading cause of death in Veterans. Inflammation in the arteries of the heart may increase the risk of cardiac death. Patients with he…
The purpose of this study is to measure cardiovascular outcomes with orforglipron compared with placebo in participants with atherosclerotic cardiovascular dise…
The aim of this study is to evaluate the risk of serious adverse cardiovascular events in adolescent and adult patients with severe asthma taking tezepelumab co…
In stent restenosis and myocardial infarction are have been linked the balance between injury and healing of the endothelium These processes can be measured res…
The purpose of this clinical trial is to determine the best initial non-invasive respiratory support (NIRS) strategy for adults who present to the emergency dep…